Source link : https://www.newshealth.biz/health-news/fda-declines-approval-of-mdma-assisted-therapy-for-ptsd/
The US Food and Drug Administration (FDA) has declined to approve a treatment that combines the psychedelic drug midomafetamine with assisted therapy (MDMA-AT) for the treatment of posttraumatic stress disorder (PTSD). In a statement, drug manufacturer Lykos Therapeutics said the agency had issued a complete response letter, determining that the therapy “could not be approved […]
Author : News Health
Publish date : 2024-08-09 22:23:09
Copyright for syndicated content belongs to the linked Source.
Categories